|
MechanismCLDN18.2 modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Qiagen Suzhou Translational Medicine
0 Patents (Medical) associated with Qiagen Suzhou Translational Medicine
100 Deals associated with Qiagen Suzhou Translational Medicine
100 Translational Medicine associated with Qiagen Suzhou Translational Medicine